Skip to main content
Equibles
KMTS logo

KMTS · Kestra Medical Technologies, Ltd.

Track KMTS — free

Use KMTS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about KMTS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$28.02 +0.28 (+1.01%) At close · Aug 14
Market Cap
$1.64B
Shares
58.60M

Kestra Medical Technologies, Ltd. Earnings Call Transcripts

Every quarterly earnings call for Kestra Medical Technologies, Ltd. (KMTS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $15.09M −$21.51M '25 Q3 25-04-14 · $17.23M −$52.05M '25 Q4 25-07-15 ▲51.5% $19.37M −$25.83M '26 Q1 25-09-11 ▲53.4% $22.57M −$32.78M '26 Q2 25-12-11 ▲62.7% $24.55M −$34.17M '26 Q3 26-03-17 LATEST ▲66.2% $28.64M −$38.84M '26 Q4 26-07-14
Earnings call
FY26 · Q4
2026-07-14
Kestra Medical Technologies, Ltd. Q4 FY2026 Earnings Call
Confident tone FY27 outlook and investments Gross margin expansion Geographic and territory coverage
Revenue
$28.64M*
▲ 66.2% YoY
Gross margin
54.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-03-17
Kestra Medical Technologies, Ltd. Q3 FY2026 Earnings Call
Confident tone Revenue growth and financial performance Sales force and territory expansion Product innovation and Assure system
Revenue
$24.55M
▲ 62.7% YoY
Diluted EPS
$-0.61
Gross margin
52.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-12-11
Kestra Medical Technologies, Ltd. Q2 FY2026 Earnings Call
Confident tone Patient Story / Outcomes Financial Performance ACE PAS Clinical Study
Revenue
$22.57M
▲ 53.4% YoY
Diluted EPS
$-0.64
Gross margin
50.6%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-09-11
Kestra Medical Technologies, Ltd. Q1 FY2026 Earnings Call
Confident tone Revenue growth and prescriptions Patient impact / mission Revenue cycle management and payer coverage
Revenue
$19.37M
▲ 51.5% YoY
Diluted EPS
$-0.50
Gross margin
45.7%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-07-15
Kestra Medical Technologies, Ltd. Q4 FY2025 Earnings Call
Revenue
$17.23M*
Gross margin
44.3%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-04-14
Kestra Medical Technologies, Ltd. Q3 FY2025 Earnings Call
Revenue
$15.09M
Diluted EPS
$-1.25
Gross margin
43.4%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts CIK 1877184 CUSIP G52441105 13F (30d) 109 filings 107 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)